DERM (Deep Ensemble for Recognition of Malignancy)
Benefits
Streamlines patient pathways by classifying lesions by risk level, supports NHS 28-day Faster Diagnosis Standard, reduces waiting times, frees up specialist capacity, provides faster accurate assessments, helps manage increasing demand while maintaining high standards of care
Details
- Tool name
- DERM (Deep Ensemble for Recognition of Malignancy)
- Status
- live
- AI method (as recorded)
- Computer Vision, Machine Learning
- AI method (normalised tags)
- Computer Vision Machine Learning
- Usecase
- Health AI
- Origin
- uhliverpool.nhs.uk
- Owning team
- Broadgreen Hospital's dermatology team, NHS University Hospitals of Liverpool (UHL) Group
- Date added
- 5 August 2025
- Scrape date
- Source note
- NICE has granted conditional approval for NHS use, recommending continued deployment for three years while further evidence is gathered. Broadgreen's dermatology team was among the UK's first to pioneer DERM at a local medical centre, integrating it into the urgent skin cancer pathway. [Source]